Annual ROE
-15.46%
+21.60%+58.28%
31 December 2023
Summary:
Beam Therapeutics annual return on equity is currently -15.46%, with the most recent change of +21.60% (+58.28%) on 31 December 2023. During the last 3 years, it has risen by +96.86% (+86.24%). BEAM annual ROE is now at all-time high.BEAM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-16.62%
-0.14%-0.85%
30 September 2024
Summary:
Beam Therapeutics quarterly return on equity is currently -16.62%, with the most recent change of -0.14% (-0.85%) on 30 September 2024. Over the past year, it has increased by +24.65% (+59.73%). BEAM quarterly ROE is now -4.79% below its all-time high of -15.86%, reached on 31 March 2024.BEAM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +58.3% | +59.7% |
| 3 y3 years | +86.2% | +81.2% |
| 5 y5 years | +82.0% | +70.4% |
BEAM ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +86.2% | -4.8% | +81.2% |
| 5 y | 5 years | at high | +86.2% | -4.8% | +87.6% |
| alltime | all time | at high | +86.2% | -4.8% | +87.6% |
Beam Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -16.62%(+0.8%) |
| June 2024 | - | -16.48%(+3.9%) |
| Mar 2024 | - | -15.86%(-2.6%) |
| Dec 2023 | -15.46%(-58.3%) | -16.29%(-60.5%) |
| Sept 2023 | - | -41.27%(-3.6%) |
| June 2023 | - | -42.81%(+3.9%) |
| Mar 2023 | - | -41.20%(+11.3%) |
| Dec 2022 | -37.06%(-46.4%) | -37.03%(-5.5%) |
| Sept 2022 | - | -39.19%(+29.3%) |
| June 2022 | - | -30.32%(-11.4%) |
| Mar 2022 | - | -34.23%(-46.5%) |
| Dec 2021 | -69.13% | -63.97%(-27.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -88.40%(-28.6%) |
| June 2021 | - | -123.75%(-7.9%) |
| Mar 2021 | - | -134.42%(+43.5%) |
| Dec 2020 | -112.32%(+68.5%) | -93.66%(+35.7%) |
| Sept 2020 | - | -69.01%(+6.9%) |
| June 2020 | - | -64.58%(+4.1%) |
| Mar 2020 | - | -62.06%(-1.9%) |
| Dec 2019 | -66.67%(-22.5%) | -63.28%(+12.7%) |
| Sept 2019 | - | -56.14%(-38.4%) |
| June 2019 | - | -91.09%(+12.4%) |
| Mar 2019 | - | -81.03%(+14.3%) |
| Dec 2018 | -85.99% | -70.88% |
FAQ
- What is Beam Therapeutics annual return on equity?
- What is the all time high annual ROE for Beam Therapeutics?
- What is Beam Therapeutics annual ROE year-on-year change?
- What is Beam Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Beam Therapeutics?
- What is Beam Therapeutics quarterly ROE year-on-year change?
What is Beam Therapeutics annual return on equity?
The current annual ROE of BEAM is -15.46%
What is the all time high annual ROE for Beam Therapeutics?
Beam Therapeutics all-time high annual return on equity is -15.46%
What is Beam Therapeutics annual ROE year-on-year change?
Over the past year, BEAM annual return on equity has changed by +21.60% (+58.28%)
What is Beam Therapeutics quarterly return on equity?
The current quarterly ROE of BEAM is -16.62%
What is the all time high quarterly ROE for Beam Therapeutics?
Beam Therapeutics all-time high quarterly return on equity is -15.86%
What is Beam Therapeutics quarterly ROE year-on-year change?
Over the past year, BEAM quarterly return on equity has changed by +24.65% (+59.73%)